特刊编辑：皮肤癌研究的现状。
Editorial to the Special Issue on Skin Cancer: The State of the Art.
机构信息
Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Skłodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.
Medical Biotechnology, Poznan University of Medical Sciences, 61-866 Poznan, Poland.
出版信息
Int J Mol Sci. 2022 Mar 30;23(7):3806. doi: 10.3390/ijms23073806.
Abstract
This Special Issue of the focuses on skin cancers, specifically on the rare forms of these tumors [...].
摘要
本期特刊聚焦于皮肤癌，特别是这些肿瘤的罕见形式[...]。
相似文献
1
Editorial to the Special Issue on Skin Cancer: The State of the Art.特刊编辑：皮肤癌研究的现状。
Int J Mol Sci. 2022 Mar 30;23(7):3806. doi: 10.3390/ijms23073806.
2
Introduction: this issue of Dermatologic Therapy focuses on rare cutaneous tumors.引言：本期《皮肤病治疗学》聚焦于罕见皮肤肿瘤。
Dermatol Ther. 2008 Nov-Dec;21(6):423. doi: 10.1111/j.1529-8019.2008.00240.x.
3
The inaugural Qatar Critical Care Conference with its Qatar Medical Journal Special Issue - An important milestone.首届卡塔尔重症监护会议及其《卡塔尔医学杂志》特刊——一个重要的里程碑。
Qatar Med J. 2019 Nov 7;2019(2):1. doi: 10.5339/qmj.2019.qccc.1. eCollection 2019.
4
Introduction to the special issue of European Journal of Surgical Oncology: New roads in melanoma management.《欧洲外科肿瘤学杂志》特刊引言：黑色素瘤治疗新路径
Eur J Surg Oncol. 2017 Mar;43(3):513-516. doi: 10.1016/j.ejso.2016.12.001. Epub 2016 Dec 14.
5
Special issue on melanoma.黑色素瘤特刊。
Cancer J. 2012 Mar-Apr;18(2):115-6. doi: 10.1097/PPO.0b013e318250f98d.
6
Editorial of Special Issue "Rare Kidney Diseases: New Translational Research Approach to Improve Diagnosis and Therapy".特刊编辑寄语：“罕见肾脏疾病：改善诊断和治疗的新转化研究方法”。
Int J Mol Sci. 2020 Jun 14;21(12):4244. doi: 10.3390/ijms21124244.
7
Editorial: New Frontiers in Skin Cancer.社论：皮肤癌的新前沿
Curr Opin Oncol. 2019 Mar;31(2):53. doi: 10.1097/CCO.0000000000000509.
8
Skin cancer and new treatment perspectives: a review.皮肤癌与新的治疗前景：综述
Cancer Lett. 2015 Feb 1;357(1):8-42. doi: 10.1016/j.canlet.2014.11.001. Epub 2014 Nov 11.
9
Gene-based immunotherapy of skin cancers.基于基因的皮肤癌免疫疗法。
Recent Results Cancer Res. 2002;160:170-84. doi: 10.1007/978-3-642-59410-6_21.
本文引用的文献
1
Molecular Profiling and Novel Therapeutic Strategies for Mucosal Melanoma: A Comprehensive Review.黏膜黑色素瘤的分子谱分析及新型治疗策略：全面综述。
Int J Mol Sci. 2021 Dec 23;23(1):147. doi: 10.3390/ijms23010147.
2
Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma.纳武利尤单抗联合伊匹单抗或纳武利尤单抗对比伊匹单抗治疗晚期黑色素瘤患者的长期结局。
J Clin Oncol. 2022 Jan 10;40(2):127-137. doi: 10.1200/JCO.21.02229. Epub 2021 Nov 24.
3
c-Kit inhibitors for unresectable or metastatic mucosal, acral or chronically sun-damaged melanoma: a systematic review and one-arm meta-analysis.无法切除或转移的黏膜、肢端或慢性日光损伤型黑色素瘤的 c-Kit 抑制剂：系统评价和单臂荟萃分析。
Eur J Cancer. 2021 Nov;157:348-357. doi: 10.1016/j.ejca.2021.08.015. Epub 2021 Sep 22.
4
Merkel Cell Carcinoma from Molecular Pathology to Novel Therapies.默克尔细胞癌：从分子病理学到新疗法。
Int J Mol Sci. 2021 Jun 11;22(12):6305. doi: 10.3390/ijms22126305.
5
Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Apocrine and Eccrine Differentiation.具有大汗腺和小汗腺分化的皮肤附件肿瘤的当前诊断和治疗选择。
Int J Mol Sci. 2021 May 11;22(10):5077. doi: 10.3390/ijms22105077.
6
Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Follicular Differentiation.具有毛囊分化的皮肤附属器肿瘤的当前诊断与治疗选择
Int J Mol Sci. 2021 Apr 30;22(9):4759. doi: 10.3390/ijms22094759.
7
Multimodal Treatment of Advanced Mucosal Melanoma in the Era of Modern Immunotherapy.现代免疫治疗时代晚期黏膜黑色素瘤的多模式治疗
Cancers (Basel). 2020 Oct 26;12(11):3131. doi: 10.3390/cancers12113131.
8
Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial.avelumab 治疗既往治疗的转移性 Merkel 细胞癌患者：来自单臂 2 期 JAVELIN Merkel 200 试验的长期数据和生物标志物分析。
J Immunother Cancer. 2020 May;8(1). doi: 10.1136/jitc-2020-000674.
9
Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.皮肤黑色素瘤：ESMO 诊断、治疗及随访临床实践指南†
Ann Oncol. 2019 Dec 1;30(12):1884-1901. doi: 10.1093/annonc/mdz411.
10
Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study (CheckMate 172).纳武利尤单抗治疗后进展的罕见黑色素瘤亚型患者的安全性和疗效：一项单臂、开放标签、Ⅱ期研究（CheckMate 172）。
Eur J Cancer. 2019 Sep;119:168-178. doi: 10.1016/j.ejca.2019.07.010. Epub 2019 Aug 21.
Zotero 插件